Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Shares

31 Mar 2021 07:00

RNS Number : 9583T
Zoetic International PLC
31 March 2021
 

For immediate release

31 March 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310 

 

Zoetic International plc

('Zoetic' or the 'Company')

 

Issue of Shares

Holding in Company

 

Zoetic, the international CBD group, has received an exercise notice from Mr John Story to exercise today the full conversion rights on the £330,000 convertible loan note issued by the Company, originally announced on 12 February 2020 (the "Loan Note"). The Loan Note was convertible at a price of 6 pence per ordinary share of 1 pence each ("Ordinary Shares"), and was capable of exercise by Mr Story, in his sole discretion, at any time. As a result, the Company has today issued 5,500,000 new Ordinary Shares to Mr Story (the "Conversion Shares") and the liability of the Loan Note has been extinguished.

 

Application will be made to the London Stock Exchange for the Conversion Shares to be admitted to trading on the Main Market of the London Stock Exchange and the Standard Segment of the FCA Official List ("Admission"). It is expected that Admission will become effective and that dealings in the Conversion Shares on the Main Market of the London Stock Exchange will commence on or around 7 April 2021.

 

On Admission, the Company will have 202,070,034 Ordinary Shares in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of Ordinary Shares and voting rights will be 202,070,034 and this figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Following Admission, and to the best of the Company's knowledge, Mr Story will have a total interest in 27,512,221 Ordinary Shares, equivalent to the 13.62 per cent of issued Ordinary Shares. Mr Story has agreed not to dispose of the Conversion Shares for a period of one year from today (the "Period"), unless the Ordinary Shares trade at a minimum mid-market closing price for 10 consecutive trading days of not less than 480p at any point during the Period.

 

- Ends -

 

Publication on website

 

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

 

 

Media enquiries:

Zoetic International plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

 

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

Nick Naylor (Corporate Finance)

 

Guy McDougall (Equity Sales)

 

 

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKBLBXFXLZBBB
Date   Source Headline
25th Jun 20204:00 pmRNSHolding(s) in Company
24th Jun 20203:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSSubscription for Equity
1st Jun 20207:00 amRNSNew Distribution Agreement and Trading Update
29th May 20207:00 amRNSFiling of Patents
27th May 20207:00 amRNSSale of DTU Interest and Kansas Nitrogen Assets
15th May 20207:00 amRNSTrading Update
11th May 20203:36 pmRNSHolding(s) in Company
6th May 20202:34 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSBoard and Strategy Changes, and Trading Update
3rd Apr 20207:00 amRNSIssue of Equity
1st Apr 20207:00 amRNSCOVID-19 Update
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSIssue of Equity
20th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20207:00 amRNSOperational update
12th Feb 20207:00 amRNSSubscription to raise £0.39 million
5th Feb 20207:00 amRNSTrading Update
23rd Dec 20197:00 amRNSInterim Results
16th Dec 20197:00 amRNSSettlement of Diversion Debt & Notice of Results
28th Nov 20197:00 amRNSResult of General Meeting
25th Nov 20197:00 amRNSTrading Update
14th Nov 20199:19 amRNSIssue of Equity
13th Nov 20192:06 pmRNSSecond Price Monitoring Extn
13th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSListing on the OTC
8th Nov 20199:01 amRNSIssue of Equity
7th Nov 20197:00 amRNSNotice of General Meeting
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
29th Oct 20194:42 pmRNSSecond Price Monitoring Extn
29th Oct 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20197:00 amRNSIssue of Shares
18th Oct 201911:05 amRNSSecond Price Monitoring Extn
18th Oct 201911:00 amRNSPrice Monitoring Extension
8th Oct 20197:00 amRNSAdoption of new share option scheme
4th Oct 20197:00 amRNSTrading Update
17th Sep 20197:00 amRNSDirectorate Change
12th Sep 201912:30 pmRNSDirector/PDMR Shareholding
9th Sep 201911:15 amRNSChange of Name
6th Sep 201910:30 amRNSDirector/PDMR Shareholding
4th Sep 201911:05 amRNSSecond Price Monitoring Extn
4th Sep 201911:00 amRNSPrice Monitoring Extension
4th Sep 20197:00 amRNSDirectorate Change
30th Aug 20194:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.